21 October 2026German multinational science and technology company Merck KGaA has announced a definitive agreement to acquire London-headquartered biotech company Silence Therapeutics.…- 15 October 2026Biopharmaceutical giant AstraZeneca has entered into a strategic drug discovery collaboration and licensing agreement with US-based artificial intelligence therapeutics specialist…
- 14 October 2026Danish biotechnology company Zealand Pharma has announced a multi-target strategic collaboration with US-based Generate Biomedicines to design and develop novel…
- 9 October 2026Global MedTech and diagnostocs leader GE HealthCare has acquired Sofie Biosciences, a privately-held developer of radiopharmaceuticals and molecular imaging diagnostics,…
6 October 2026Dr Gary Crotaz, podcaster, speaker, executive coach, and author on the topic of leadership, talks about: Find out more about…- 5 October 2026Listed Danish pharmaceutical giant H. Lundbeck is divesting its Italian manufacturing subsidiary, Lundbeck Pharmaceuticals Italy, to Flamma, a privately owned…
- 5 October 2026Global biopharmaceutical company AstraZeneca has completed a two billion dollar strategic transaction with US, UK and Ireland-based oncology specialist Summit…
5 October 2026AI is changing the economics of the outsourced pharma-services market. But will it hurt CROs by making drug development more…- 29 September 2026German global life science and pharmaceutical company Bayer has divested its established oncology asset Stivarga to the German pharmaceutical firm…
- 29 September 2026Novo Nordisk has has secured an exclusive global licensing agreement with Hengrui Pharma for HRS-1596. Announced on September 29, the…
